LekoskopLekoskop
UK · ES · FR · CS · IT · NL · CH · HR · PL

Drug Safety Update — United Kingdom

MHRA medicines recalls and defect notifications with batch numbers, Serious Shortage Protocols, new approvals and Drug Safety Update — updated daily, automatically. Last updated: 27 Sep 2026 13:39.

All Recalls and defects2 Serious shortages (SSP)2 New approvals1 Drug Safety Update1

Sources: we track changes based on information published by the MHRA — medicines recalls and defect notifications, Drug Safety Update and approval announcements — and the Serious Shortage Protocols published by the NHS Business Services Authority. The UK is outside the EU, so European Commission decisions are not listed here.

expand all dayscollapse all days

2 Sep 2026Wednesday 2 September 2026

open day ◀ ▶ 1 event · 1 important
Drug Safety Update Filters should be used during the administration of Parenteral Nutrition for patients in all care settings
Administration of parenteral nutrition without a filter has been associated with a number of adverse incidents including an embolism which resulted in a fatal outcome.
What this means, batches, details

Loading…

Drug Safety Update on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency

21 Jul 2026Tuesday 21 July 2026

open day ◀ ▶ 1 event · 1 important
Drug Safety Update Domperidone
The product information has been updated for all domperidone products, to include a contraindication for patients with confirmed or suspected phaeochromocytoma (a rare tumour of the adrenal gland), du…
What this means, batches, details

Loading…

Drug Safety Update on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency

15 Jul 2026Wednesday 15 July 2026

open day ◀ ▶ 1 event · 1 important
Drug Safety Update Botulinum toxin type A products
Cases of iatrogenic botulism have been reported following the therapeutic or cosmetic use of botulinum toxin containing products where the toxin’s effect extends beyond the area of treatment. Patients…
What this means, batches, details

Loading…

Drug Safety Update on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency

16 Jun 2026Tuesday 16 June 2026

open day ◀ ▶ 1 event · 1 important
Drug Safety Update ACE
Healthcare professionals should be aware of the potential for delayed onset of angioedema and the distinction between bradykinin- and histamine-mediated cases, as treatment strategies differ significa…
What this means, batches, details

Loading…

Drug Safety Update on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency

20 May 2026Wednesday 20 May 2026

open day ◀ ▶ 1 event · 1 important
Drug Safety Update Amiodarone
Amiodarone has been associated with serious and potentially life-threatening side effects, particularly of the lung, liver, and thyroid gland. We remind healthcare professionals that patients should b…
What this means, batches, details

Loading…

Drug Safety Update on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency
older days →

In total 59 events in this category.